Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Elattar S, Basha NR, Salem A, et. al. "Tadalafil for Treatment of Pulmonary Hypertension: Mechanisms, Evidence, and Emerging Perspectives." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001036
- Tran HH, Thu A, Twayana AR, et. al. "The Role of Generative Artificial Intelligence and Large Language Models in Atrial Fibrillation: Clinical Research and Decision Support." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001042
- Thapa S, Shah S, Dahal K, et. al. "Headache Outcomes After Treatment of Cerebral Arteriovenous Malformations: A Systematic Review and Meta-Analysis with Clinical Implications." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001041
- Tran HH, Thu A, Brilhante M, et. al. "Evidence-Based Quality Improvement Strategies to Reduce 30-Day Readmission Rates in Heart Failure Patients." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001039
- Tripathi A, Arsha S, Casey D, et. al. "Perioperative Anticoagulation Management: Revisiting Bridging Strategies for Mechanical and Nonmechanical Indications." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001037
- Arun AJ, Darji B, Baig M, et. al. "From Evidence to Bedside: The Role of Short-Acting β-Blockers in Sepsis Care." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001040
- Ahmad R, Frishman WH, Aronow WS, et. al. "Protein Kinase Inhibitors in Heart Failure: Mechanistic Insights and Therapeutic Prospects." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001038
